Gene Expression Signatures Predicting Survival and Chemotherapy Benefit in Patients with Resected Non-small-Cell Lung Cancer

Benzer Materyaller

• Co-mutations in EGFR driven non-small cell lung cancer
  Yazar:: Rosell, Rafael, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Targeted treatment of mutated EGFR-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnostics
  Yazar:: Karachaliou, Niki, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer
  Yazar:: Van Laar, Ryan K
  Baskı/Yayın Bilgisi: (2012)
• Expression Profiles and Clinicopathologic Features in Early Resected Non-small-cell Lung Cancer()
  Yazar:: Rosell, Rafael
  Baskı/Yayın Bilgisi: (2014)
• Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non–Small-Cell Lung Cancer
  Yazar:: Zhu, Chang-Qi, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)